Neurogene Inc. Public Float
Neurogene Inc. (NGNE) had Public Float of $145.98 million as of 2025-06-30, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-24
- 2025-06-30: Entity Public Float $145.98M.
- 2024-06-30: Entity Public Float $375.99M.
- 2023-06-30: Entity Public Float $33.35M.
- 2022-06-30: Entity Public Float $36.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $145.98M 10-K · filed 2026-03-24 |
| 2024-06-30 | $375.99M 10-K · filed 2025-03-24 |
| 2023-06-30 | $33.35M 10-K · filed 2024-03-18 |
| 2022-06-30 | $36.10M 10-K · filed 2023-03-20 |
| 2021-06-30 | $322.80M 10-K · filed 2022-03-01 |
| 2020-06-30 | $546.00M 10-K · filed 2021-03-25 |
| 2019-06-30 | $24.20M 10-K · filed 2020-03-12 |
| 2018-06-30 | $33.20M 10-K · filed 2019-03-07 |
| 2017-06-30 | $54.60M 10-K · filed 2018-03-12 |
| 2016-06-30 | $62.10M 10-K · filed 2017-03-09 |
| 2015-06-30 | $45.30M 10-K · filed 2016-03-14 |
| 2014-06-30 | $41.57M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |